{"id": "HPRD50.d1.s1_HPRD50.d1.s1.p0", "text": "The receptor binding site of MCP-1 also is significantly different from the binding sites of RANTES and IL-8, providing insight into the issue of receptor specificity", "text_with_entity_marker": "The receptor binding site of [E1]MCP-1[/E1] also is significantly different from the binding sites of [E2]RANTES[/E2] and IL-8, providing insight into the issue of receptor specificity", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MCP-1", "entity_1_idx": [[29, 34]], "entity_1_idx_in_text_with_entity_marker": [33, 38], "entity_1_type": "pm0111607||pm0117207||pm0124628", "entity_1_type_id": 5, "entity_2": "RANTES", "entity_2_idx": [[93, 99]], "entity_2_idx_in_text_with_entity_marker": [106, 112], "entity_2_type": "pm0105763", "entity_2_type_id": 6}], "directed": false, "reverse": false}
{"id": "HPRD50.d2.s0_HPRD50.d2.s0.p0", "text": "We tested this point by cotransfecting CHO cells with the genes encoding F beta alpha and the CG beta subunit or the CG beta alpha and FSH beta monomer", "text_with_entity_marker": "We tested this point by cotransfecting CHO cells with the genes encoding F beta alpha and the [E1]CG beta[/E1] subunit or the [E2]CG beta alpha[/E2] and FSH beta monomer", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CG beta", "entity_1_idx": [[94, 101]], "entity_1_idx_in_text_with_entity_marker": [98, 105], "entity_1_type": "pm0125097", "entity_1_type_id": 8, "entity_2": "CG beta alpha", "entity_2_idx": [[117, 130]], "entity_2_idx_in_text_with_entity_marker": [130, 143], "entity_2_type": "pm0125097", "entity_2_type_id": 8}], "directed": false, "reverse": false}
{"id": "HPRD50.d2.s3_HPRD50.d2.s3.p2", "text": "Previously, we showed that the CG beta or FSH beta subunit genes can be genetically fused to the alpha gene to produce biologically active single chains, CG beta alpha and F beta alpha, respectively", "text_with_entity_marker": "Previously, we showed that the CG beta or [E1]FSH beta[/E1] subunit genes can be genetically fused to the alpha gene to produce biologically active single chains, [E2]CG beta alpha[/E2] and F beta alpha, respectively", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FSH beta", "entity_1_idx": [[42, 50]], "entity_1_idx_in_text_with_entity_marker": [46, 54], "entity_1_type": "pm0104723", "entity_1_type_id": 9, "entity_2": "CG beta alpha", "entity_2_idx": [[154, 167]], "entity_2_idx_in_text_with_entity_marker": [167, 180], "entity_2_type": "pm0125097", "entity_2_type_id": 8}], "directed": false, "reverse": false}
{"id": "HPRD50.d4.s1_HPRD50.d4.s1.p3", "text": "Immobilized FGFR4 also bound FGF-8 besides FGF-1 and FGF-2", "text_with_entity_marker": "Immobilized FGFR4 also bound [E1]FGF-8[/E1] besides [E2]FGF-1[/E2] and FGF-2", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FGF-8", "entity_1_idx": [[29, 34]], "entity_1_idx_in_text_with_entity_marker": [33, 38], "entity_1_type": "pm0118903", "entity_1_type_id": 19, "entity_2": "FGF-1", "entity_2_idx": [[43, 48]], "entity_2_idx_in_text_with_entity_marker": [56, 61], "entity_2_type": "pm0124654", "entity_2_type_id": 16}], "directed": false, "reverse": false}
{"id": "HPRD50.d7.s1_HPRD50.d7.s1.p0", "text": "Deletion analysis showed that the element responsible for the PPARgamma effect is located in a region containing the nuclear factor E2 (NF-E2)/AP-1 site (-98/-88), which was indicated to be the major promoter of the TXS gene", "text_with_entity_marker": "Deletion analysis showed that the element responsible for the PPARgamma effect is located in a region containing the nuclear factor E2 ([E1]NF-E2[/E1])/[E2]AP-1[/E2] site (-98/-88), which was indicated to be the major promoter of the TXS gene", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NF-E2", "entity_1_idx": [[136, 141]], "entity_1_idx_in_text_with_entity_marker": [140, 145], "entity_1_type": "pm0120477", "entity_1_type_id": 28, "entity_2": "AP-1", "entity_2_idx": [[143, 147]], "entity_2_idx_in_text_with_entity_marker": [156, 160], "entity_2_type": "pm0103880", "entity_2_type_id": 29}], "directed": false, "reverse": false}
{"id": "HPRD50.d9.s0_HPRD50.d9.s0.p0", "text": "Here, we cloned and characterized a mouse orthologue of human KIAA1427 protein as an atypical Syt (named Syt XIII)", "text_with_entity_marker": "Here, we cloned and characterized a mouse orthologue of human [E1]KIAA1427[/E1] protein as an atypical [E2]Syt[/E2] (named Syt XIII)", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "KIAA1427", "entity_1_idx": [[62, 70]], "entity_1_idx_in_text_with_entity_marker": [66, 74], "entity_1_type": "pm0110335", "entity_1_type_id": 34, "entity_2": "Syt", "entity_2_idx": [[94, 97]], "entity_2_idx_in_text_with_entity_marker": [107, 110], "entity_2_type": "pm0109470||pm0116152", "entity_2_type_id": 35}], "directed": false, "reverse": false}
{"id": "HPRD50.d11.s0_HPRD50.d11.s0.p0", "text": "Direct interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of p85alpha activates phosphatidylinositol 3-kinase in C2C12 cells", "text_with_entity_marker": "Direct interaction between the cytoplasmic tail of [E1]ADAM 12[/E1] and the Src homology 3 domain of [E2]p85alpha[/E2] activates phosphatidylinositol 3-kinase in C2C12 cells", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ADAM 12", "entity_1_idx": [[51, 58]], "entity_1_idx_in_text_with_entity_marker": [55, 62], "entity_1_type": "pm0118647", "entity_1_type_id": 39, "entity_2": "p85alpha", "entity_2_idx": [[92, 100]], "entity_2_idx_in_text_with_entity_marker": [105, 113], "entity_2_type": "pm0124741", "entity_2_type_id": 40}], "directed": false, "reverse": false}
{"id": "HPRD50.d13.s2_HPRD50.d13.s2.p0", "text": "This work suggests that LIS1 is a regulated adapter between CLIP-170 and cytoplasmic dynein at sites involved in cargo-MT loading, and/or in the control of MT dynamics", "text_with_entity_marker": "This work suggests that [E1]LIS1[/E1] is a regulated adapter between [E2]CLIP-170[/E2] and cytoplasmic dynein at sites involved in cargo-MT loading, and/or in the control of MT dynamics", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIS1", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "pm0110467", "entity_1_type_id": 44, "entity_2": "CLIP-170", "entity_2_idx": [[60, 68]], "entity_2_idx_in_text_with_entity_marker": [73, 81], "entity_2_type": "pm0124985", "entity_2_type_id": 43}], "directed": false, "reverse": false}
{"id": "HPRD50.d16.s1_HPRD50.d16.s1.p0", "text": "Gadd45a (Gadd45), Gadd45b (MyD118), and Gadd45g (CR6) constitute a family of evolutionarily conserved, small, acidic, nuclear proteins, which have been implicated in terminal differentiation, growth suppression, and apoptosis", "text_with_entity_marker": "[E1]Gadd45a[/E1] ([E2]Gadd45[/E2]), Gadd45b (MyD118), and Gadd45g (CR6) constitute a family of evolutionarily conserved, small, acidic, nuclear proteins, which have been implicated in terminal differentiation, growth suppression, and apoptosis", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Gadd45a", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "pm0112301", "entity_1_type_id": 54, "entity_2": "Gadd45", "entity_2_idx": [[9, 15]], "entity_2_idx_in_text_with_entity_marker": [22, 28], "entity_2_type": "pm0112301", "entity_2_type_id": 54}], "directed": false, "reverse": false}
{"id": "HPRD50.d16.s1_HPRD50.d16.s1.p8", "text": "Gadd45a (Gadd45), Gadd45b (MyD118), and Gadd45g (CR6) constitute a family of evolutionarily conserved, small, acidic, nuclear proteins, which have been implicated in terminal differentiation, growth suppression, and apoptosis", "text_with_entity_marker": "Gadd45a ([E1]Gadd45[/E1]), Gadd45b (MyD118), and Gadd45g ([E2]CR6[/E2]) constitute a family of evolutionarily conserved, small, acidic, nuclear proteins, which have been implicated in terminal differentiation, growth suppression, and apoptosis", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Gadd45", "entity_1_idx": [[9, 15]], "entity_1_idx_in_text_with_entity_marker": [13, 19], "entity_1_type": "pm0112301", "entity_1_type_id": 54, "entity_2": "CR6", "entity_2_idx": [[49, 52]], "entity_2_idx_in_text_with_entity_marker": [62, 65], "entity_2_type": "pm0102392||pm0116690", "entity_2_type_id": 55}], "directed": false, "reverse": false}
{"id": "HPRD50.d16.s1_HPRD50.d16.s1.p11", "text": "Gadd45a (Gadd45), Gadd45b (MyD118), and Gadd45g (CR6) constitute a family of evolutionarily conserved, small, acidic, nuclear proteins, which have been implicated in terminal differentiation, growth suppression, and apoptosis", "text_with_entity_marker": "Gadd45a (Gadd45), [E1]Gadd45b[/E1] (MyD118), and Gadd45g ([E2]CR6[/E2]) constitute a family of evolutionarily conserved, small, acidic, nuclear proteins, which have been implicated in terminal differentiation, growth suppression, and apoptosis", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Gadd45b", "entity_1_idx": [[18, 25]], "entity_1_idx_in_text_with_entity_marker": [22, 29], "entity_1_type": "pm0114403", "entity_1_type_id": 51, "entity_2": "CR6", "entity_2_idx": [[49, 52]], "entity_2_idx_in_text_with_entity_marker": [62, 65], "entity_2_type": "pm0102392||pm0116690", "entity_2_type_id": 55}], "directed": false, "reverse": false}
{"id": "HPRD50.d19.s2_HPRD50.d19.s2.p0", "text": "Our findings showed that the same C-terminal portion of p300 binds the N-terminal domains of both TR and MEF2A, and our in vivo studies demonstrated that TR, MEF2A and p300 form a ternary complex", "text_with_entity_marker": "Our findings showed that the same C-terminal portion of [E1]p300[/E1] binds the N-terminal domains of both TR and [E2]MEF2A[/E2], and our in vivo studies demonstrated that TR, MEF2A and p300 form a ternary complex", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p300", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "pm0126787", "entity_1_type_id": 65, "entity_2": "MEF2A", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "pm0122391", "entity_2_type_id": 67}], "directed": false, "reverse": false}
{"id": "HPRD50.d19.s2_HPRD50.d19.s2.p2", "text": "Our findings showed that the same C-terminal portion of p300 binds the N-terminal domains of both TR and MEF2A, and our in vivo studies demonstrated that TR, MEF2A and p300 form a ternary complex", "text_with_entity_marker": "Our findings showed that the same C-terminal portion of [E1]p300[/E1] binds the N-terminal domains of both TR and MEF2A, and our in vivo studies demonstrated that TR, MEF2A and [E2]p300[/E2] form a ternary complex", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p300", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "pm0126787", "entity_1_type_id": 65, "entity_2": "p300", "entity_2_idx": [[168, 172]], "entity_2_idx_in_text_with_entity_marker": [181, 185], "entity_2_type": "pm0126787", "entity_2_type_id": 65}], "directed": false, "reverse": false}
{"id": "HPRD50.d20.s2_HPRD50.d20.s2.p0", "text": "The results of complementation experiments show that, in contrast to mouse Imp4, mouse Imp3 can partially alleviate the growth defect of the corresponding yeast null strain, indicating that the role of Imp3 in pre-rRNA processing is evolutionarily conserved", "text_with_entity_marker": "The results of complementation experiments show that, in contrast to mouse [E1]Imp4[/E1], mouse [E2]Imp3[/E2] can partially alleviate the growth defect of the corresponding yeast null strain, indicating that the role of Imp3 in pre-rRNA processing is evolutionarily conserved", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Imp4", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "pm0104160||pm0117832", "entity_1_type_id": 69, "entity_2": "Imp3", "entity_2_idx": [[87, 91]], "entity_2_idx_in_text_with_entity_marker": [100, 104], "entity_2_type": "pm0100548||pm0102353||pm0121765", "entity_2_type_id": 68}], "directed": false, "reverse": false}
{"id": "HPRD50.d20.s2_HPRD50.d20.s2.p1", "text": "The results of complementation experiments show that, in contrast to mouse Imp4, mouse Imp3 can partially alleviate the growth defect of the corresponding yeast null strain, indicating that the role of Imp3 in pre-rRNA processing is evolutionarily conserved", "text_with_entity_marker": "The results of complementation experiments show that, in contrast to mouse [E1]Imp4[/E1], mouse Imp3 can partially alleviate the growth defect of the corresponding yeast null strain, indicating that the role of [E2]Imp3[/E2] in pre-rRNA processing is evolutionarily conserved", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Imp4", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "pm0104160||pm0117832", "entity_1_type_id": 69, "entity_2": "Imp3", "entity_2_idx": [[202, 206]], "entity_2_idx_in_text_with_entity_marker": [215, 219], "entity_2_type": "pm0100548||pm0102353||pm0121765", "entity_2_type_id": 68}], "directed": false, "reverse": false}
{"id": "HPRD50.d20.s3_HPRD50.d20.s3.p1", "text": "The results of density gradient centrifugation experiments show that, in contrast to hU3-55K, the human Imp3 and Imp4 proteins predominantly interact with the U3 snoRNA in 60-80S ribonucleoprotein complexes", "text_with_entity_marker": "The results of density gradient centrifugation experiments show that, in contrast to hU3-55K, the human [E1]Imp3[/E1] and Imp4 proteins predominantly interact with the U3 [E2]snoRNA[/E2] in 60-80S ribonucleoprotein complexes", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Imp3", "entity_1_idx": [[104, 108]], "entity_1_idx_in_text_with_entity_marker": [108, 112], "entity_1_type": "pm0100548||pm0102353||pm0121765", "entity_1_type_id": 68, "entity_2": "snoRNA", "entity_2_idx": [[162, 168]], "entity_2_idx_in_text_with_entity_marker": [175, 181], "entity_2_type": "pm0114346", "entity_2_type_id": 70}], "directed": false, "reverse": false}
{"id": "HPRD50.d20.s3_HPRD50.d20.s3.p2", "text": "The results of density gradient centrifugation experiments show that, in contrast to hU3-55K, the human Imp3 and Imp4 proteins predominantly interact with the U3 snoRNA in 60-80S ribonucleoprotein complexes", "text_with_entity_marker": "The results of density gradient centrifugation experiments show that, in contrast to hU3-55K, the human Imp3 and [E1]Imp4[/E1] proteins predominantly interact with the U3 [E2]snoRNA[/E2] in 60-80S ribonucleoprotein complexes", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Imp4", "entity_1_idx": [[113, 117]], "entity_1_idx_in_text_with_entity_marker": [117, 121], "entity_1_type": "pm0104160||pm0117832", "entity_1_type_id": 69, "entity_2": "snoRNA", "entity_2_idx": [[162, 168]], "entity_2_idx_in_text_with_entity_marker": [175, 181], "entity_2_type": "pm0114346", "entity_2_type_id": 70}], "directed": false, "reverse": false}
{"id": "HPRD50.d22.s1_HPRD50.d22.s1.p3", "text": "Gab1 and Gab2 are scaffolding proteins acting downstream of cell surface receptors and interact with a variety of cytoplasmic signaling proteins such as Grb2, Shp-2, phosphatidylinositol 3-kinase, Shc, and Crk", "text_with_entity_marker": "[E1]Gab1[/E1] and Gab2 are scaffolding proteins acting downstream of cell surface receptors and interact with a variety of cytoplasmic signaling proteins such as Grb2, Shp-2, [E2]phosphatidylinositol 3-kinase[/E2], Shc, and Crk", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Gab1", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "pm0112697", "entity_1_type_id": 75, "entity_2": "phosphatidylinositol 3-kinase", "entity_2_idx": [[166, 195]], "entity_2_idx_in_text_with_entity_marker": [179, 208], "entity_2_type": "pm0104655||pm0110290||pm0120114||pm0122783||pm0124741", "entity_2_type_id": 12}], "directed": false, "reverse": false}
{"id": "HPRD50.d22.s1_HPRD50.d22.s1.p4", "text": "Gab1 and Gab2 are scaffolding proteins acting downstream of cell surface receptors and interact with a variety of cytoplasmic signaling proteins such as Grb2, Shp-2, phosphatidylinositol 3-kinase, Shc, and Crk", "text_with_entity_marker": "Gab1 and [E1]Gab2[/E1] are scaffolding proteins acting downstream of cell surface receptors and interact with a variety of cytoplasmic signaling proteins such as [E2]Grb2[/E2], Shp-2, phosphatidylinositol 3-kinase, Shc, and Crk", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Gab2", "entity_1_idx": [[9, 13]], "entity_1_idx_in_text_with_entity_marker": [13, 17], "entity_1_type": "pm0111574", "entity_1_type_id": 76, "entity_2": "Grb2", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "pm0105419", "entity_2_type_id": 77}], "directed": false, "reverse": false}
{"id": "HPRD50.d22.s1_HPRD50.d22.s1.p7", "text": "Gab1 and Gab2 are scaffolding proteins acting downstream of cell surface receptors and interact with a variety of cytoplasmic signaling proteins such as Grb2, Shp-2, phosphatidylinositol 3-kinase, Shc, and Crk", "text_with_entity_marker": "Gab1 and Gab2 are scaffolding proteins acting downstream of cell surface receptors and interact with a variety of cytoplasmic signaling proteins such as [E1]Grb2[/E1], [E2]Shp-2[/E2], phosphatidylinositol 3-kinase, Shc, and Crk", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Grb2", "entity_1_idx": [[153, 157]], "entity_1_idx_in_text_with_entity_marker": [157, 161], "entity_1_type": "pm0105419", "entity_1_type_id": 77, "entity_2": "Shp-2", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "pm0122382", "entity_2_type_id": 78}], "directed": false, "reverse": false}
{"id": "HPRD50.d22.s3_HPRD50.d22.s3.p0", "text": "We propose that Gab1 and Gab2 in cooperation with other adapter molecules might regulate the cellular localization of GC-GAP under specific stimuli, acting to regulate precisely Rac and Cdc42 activities", "text_with_entity_marker": "We propose that [E1]Gab1[/E1] and [E2]Gab2[/E2] in cooperation with other adapter molecules might regulate the cellular localization of GC-GAP under specific stimuli, acting to regulate precisely Rac and Cdc42 activities", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Gab1", "entity_1_idx": [[16, 20]], "entity_1_idx_in_text_with_entity_marker": [20, 24], "entity_1_type": "pm0112697", "entity_1_type_id": 75, "entity_2": "Gab2", "entity_2_idx": [[25, 29]], "entity_2_idx_in_text_with_entity_marker": [38, 42], "entity_2_type": "pm0111574", "entity_2_type_id": 76}], "directed": false, "reverse": false}
{"id": "HPRD50.d22.s3_HPRD50.d22.s3.p3", "text": "We propose that Gab1 and Gab2 in cooperation with other adapter molecules might regulate the cellular localization of GC-GAP under specific stimuli, acting to regulate precisely Rac and Cdc42 activities", "text_with_entity_marker": "We propose that Gab1 and [E1]Gab2[/E1] in cooperation with other adapter molecules might regulate the cellular localization of [E2]GC-GAP[/E2] under specific stimuli, acting to regulate precisely Rac and Cdc42 activities", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Gab2", "entity_1_idx": [[25, 29]], "entity_1_idx_in_text_with_entity_marker": [29, 33], "entity_1_type": "pm0111574", "entity_1_type_id": 76, "entity_2": "GC-GAP", "entity_2_idx": [[118, 124]], "entity_2_idx_in_text_with_entity_marker": [131, 137], "entity_2_type": "pm0122639", "entity_2_type_id": 73}], "directed": false, "reverse": false}
{"id": "HPRD50.d22.s6_HPRD50.d22.s6.p2", "text": "The protein was named GC-GAP for its ability to interact with GAB proteins and its activity toward Rac and Cdc42", "text_with_entity_marker": "The protein was named GC-GAP for its ability to interact with [E1]GAB[/E1] proteins and its activity toward Rac and [E2]Cdc42[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GAB", "entity_1_idx": [[62, 65]], "entity_1_idx_in_text_with_entity_marker": [66, 69], "entity_1_type": "pm0100534", "entity_1_type_id": 84, "entity_2": "Cdc42", "entity_2_idx": [[107, 112]], "entity_2_idx_in_text_with_entity_marker": [120, 125], "entity_2_type": "pm0110789", "entity_2_type_id": 80}], "directed": false, "reverse": false}
{"id": "HPRD50.d22.s7_HPRD50.d22.s7.p0", "text": "Expression of GC-GAP in 293T cells led to a reduction in active Rac1 and Cdc42 levels but not RhoA", "text_with_entity_marker": "Expression of [E1]GC-GAP[/E1] in 293T cells led to a reduction in active [E2]Rac1[/E2] and Cdc42 levels but not RhoA", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GC-GAP", "entity_1_idx": [[14, 20]], "entity_1_idx_in_text_with_entity_marker": [18, 24], "entity_1_type": "pm0122639", "entity_1_type_id": 73, "entity_2": "Rac1", "entity_2_idx": [[64, 68]], "entity_2_idx_in_text_with_entity_marker": [77, 81], "entity_2_type": "pm0109115", "entity_2_type_id": 83}], "directed": false, "reverse": false}
{"id": "HPRD50.d23.s1_HPRD50.d23.s1.p8", "text": "Here, we characterize the interaction between Plk1 and NudC, show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro, and present evidence that NudC is also a substrate for Plk1 in vivo", "text_with_entity_marker": "Here, we characterize the interaction between Plk1 and [E1]NudC[/E1], show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro, and present evidence that NudC is also a substrate for [E2]Plk1[/E2] in vivo", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NudC", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "pm0116104", "entity_1_type_id": 86, "entity_2": "Plk1", "entity_2_idx": [[197, 201]], "entity_2_idx_in_text_with_entity_marker": [210, 214], "entity_2_type": "pm0109061", "entity_2_type_id": 85}], "directed": false, "reverse": false}
{"id": "HPRD50.d23.s1_HPRD50.d23.s1.p14", "text": "Here, we characterize the interaction between Plk1 and NudC, show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro, and present evidence that NudC is also a substrate for Plk1 in vivo", "text_with_entity_marker": "Here, we characterize the interaction between Plk1 and NudC, show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro, and present evidence that [E1]NudC[/E1] is also a substrate for [E2]Plk1[/E2] in vivo", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "NudC", "entity_1_idx": [[168, 172]], "entity_1_idx_in_text_with_entity_marker": [172, 176], "entity_1_type": "pm0116104", "entity_1_type_id": 86, "entity_2": "Plk1", "entity_2_idx": [[197, 201]], "entity_2_idx_in_text_with_entity_marker": [210, 214], "entity_2_type": "pm0109061", "entity_2_type_id": 85}], "directed": false, "reverse": false}
{"id": "HPRD50.d25.s0_HPRD50.d25.s0.p2", "text": "TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC-3", "text_with_entity_marker": "TR2 orphan receptor functions as negative modulator for [E1]androgen receptor[/E1] in prostate cancer cells [E2]PC-3[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "androgen receptor", "entity_1_idx": [[56, 73]], "entity_1_idx_in_text_with_entity_marker": [60, 77], "entity_1_type": "pm0125088", "entity_1_type_id": 91, "entity_2": "PC-3", "entity_2_idx": [[99, 103]], "entity_2_idx_in_text_with_entity_marker": [112, 116], "entity_2_type": "pm0107379||pm0107715||pm0114827", "entity_2_type_id": 13}], "directed": false, "reverse": false}
{"id": "HPRD50.d25.s2_HPRD50.d25.s2.p2", "text": "The interaction between AR and TR2 was assessed by glutathione-S-transferase (GST) pull-down assay and mammalian two-hybrid system assay", "text_with_entity_marker": "The interaction between AR and TR2 was assessed by [E1]glutathione-S-transferase[/E1] ([E2]GST[/E2]) pull-down assay and mammalian two-hybrid system assay", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "glutathione-S-transferase", "entity_1_idx": [[51, 76]], "entity_1_idx_in_text_with_entity_marker": [55, 80], "entity_1_type": "pm0116848", "entity_1_type_id": 31, "entity_2": "GST", "entity_2_idx": [[78, 81]], "entity_2_idx_in_text_with_entity_marker": [91, 94], "entity_2_type": "pm0116848", "entity_2_type_id": 31}], "directed": false, "reverse": false}
{"id": "HPRD50.d28.s2_HPRD50.d28.s2.p0", "text": "In contrast, phosphorylation of SMC1 by ATR is independent of Rad17 and replication protein A, suggesting that the signaling pathway leading to SMC1 phosphorylation is distinct from that mediated by the checkpoint proteins", "text_with_entity_marker": "In contrast, phosphorylation of [E1]SMC1[/E1] by ATR is independent of [E2]Rad17[/E2] and replication protein A, suggesting that the signaling pathway leading to SMC1 phosphorylation is distinct from that mediated by the checkpoint proteins", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SMC1", "entity_1_idx": [[32, 36]], "entity_1_idx_in_text_with_entity_marker": [36, 40], "entity_1_type": "pm0116233", "entity_1_type_id": 101, "entity_2": "Rad17", "entity_2_idx": [[62, 67]], "entity_2_idx_in_text_with_entity_marker": [75, 80], "entity_2_type": "pm0117336", "entity_2_type_id": 102}], "directed": false, "reverse": false}
{"id": "HPRD50.d29.s1_HPRD50.d29.s1.p7", "text": "Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery, namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and PIASxalpha, all of which are involved in conjugating the small ubiquitin-like modifier polypeptide, SUMO-1, to its target proteins", "text_with_entity_marker": "Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery, namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases [E1]PIAS1[/E1] and [E2]PIASxalpha[/E2], all of which are involved in conjugating the small ubiquitin-like modifier polypeptide, SUMO-1, to its target proteins", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PIAS1", "entity_1_idx": [[157, 162]], "entity_1_idx_in_text_with_entity_marker": [161, 166], "entity_1_type": "pm0117395", "entity_1_type_id": 106, "entity_2": "PIASxalpha", "entity_2_idx": [[167, 177]], "entity_2_idx_in_text_with_entity_marker": [180, 190], "entity_2_type": "pm0119764", "entity_2_type_id": 107}], "directed": false, "reverse": false}
{"id": "HPRD50.d29.s1_HPRD50.d29.s1.p8", "text": "Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery, namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and PIASxalpha, all of which are involved in conjugating the small ubiquitin-like modifier polypeptide, SUMO-1, to its target proteins", "text_with_entity_marker": "Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery, namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases [E1]PIAS1[/E1] and PIASxalpha, all of which are involved in conjugating the small ubiquitin-like modifier polypeptide, [E2]SUMO-1[/E2], to its target proteins", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PIAS1", "entity_1_idx": [[157, 162]], "entity_1_idx_in_text_with_entity_marker": [161, 166], "entity_1_type": "pm0117395", "entity_1_type_id": 106, "entity_2": "SUMO-1", "entity_2_idx": [[267, 273]], "entity_2_idx_in_text_with_entity_marker": [280, 286], "entity_2_type": "pm0108344", "entity_2_type_id": 104}], "directed": false, "reverse": false}
{"id": "HPRD50.d29.s2_HPRD50.d29.s2.p2", "text": "Dnmt3a is modified by SUMO-1 in vivo and in vitro and the region of Dnmt3a responsible for interaction maps to the N-terminal regulatory domain", "text_with_entity_marker": "Dnmt3a is modified by [E1]SUMO-1[/E1] in vivo and in vitro and the region of [E2]Dnmt3a[/E2] responsible for interaction maps to the N-terminal regulatory domain", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SUMO-1", "entity_1_idx": [[22, 28]], "entity_1_idx_in_text_with_entity_marker": [26, 32], "entity_1_type": "pm0108344", "entity_1_type_id": 104, "entity_2": "Dnmt3a", "entity_2_idx": [[68, 74]], "entity_2_idx_in_text_with_entity_marker": [81, 87], "entity_2_type": "pm0106301", "entity_2_type_id": 103}], "directed": false, "reverse": false}
{"id": "HPRD50.d32.s0_HPRD50.d32.s0.p0", "text": "Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease", "text_with_entity_marker": "Differential binding of vascular cell-derived proteoglycans ([E1]perlecan[/E1], [E2]biglycan[/E2], decorin, and versican) to the beta-amyloid protein of Alzheimer's disease", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "perlecan", "entity_1_idx": [[61, 69]], "entity_1_idx_in_text_with_entity_marker": [65, 73], "entity_1_type": "pm0116983", "entity_1_type_id": 114, "entity_2": "biglycan", "entity_2_idx": [[71, 79]], "entity_2_idx_in_text_with_entity_marker": [84, 92], "entity_2_type": "pm0124379", "entity_2_type_id": 115}], "directed": false, "reverse": false}
{"id": "HPRD50.d32.s6_HPRD50.d32.s6.p4", "text": "Characterization of EC and SMC PGs bound to A beta (1-28) revealed strong binding by perlecan, weak binding by decorin and biglycan, two dermatan sulfate proteoglycans, and lack of binding by versican/PG-M, a large chondroitin sulfate proteoglycan", "text_with_entity_marker": "Characterization of EC and [E1]SMC[/E1] PGs bound to A beta (1-28) revealed strong binding by perlecan, weak binding by decorin and biglycan, two dermatan sulfate proteoglycans, and lack of binding by [E2]versican[/E2]/PG-M, a large chondroitin sulfate proteoglycan", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SMC", "entity_1_idx": [[27, 30]], "entity_1_idx_in_text_with_entity_marker": [31, 34], "entity_1_type": "pm0101876", "entity_1_type_id": 122, "entity_2": "versican", "entity_2_idx": [[192, 200]], "entity_2_idx_in_text_with_entity_marker": [205, 213], "entity_2_type": "pm0106611", "entity_2_type_id": 117}], "directed": false, "reverse": false}
{"id": "HPRD50.d32.s6_HPRD50.d32.s6.p11", "text": "Characterization of EC and SMC PGs bound to A beta (1-28) revealed strong binding by perlecan, weak binding by decorin and biglycan, two dermatan sulfate proteoglycans, and lack of binding by versican/PG-M, a large chondroitin sulfate proteoglycan", "text_with_entity_marker": "Characterization of EC and SMC PGs bound to A beta (1-28) revealed strong binding by [E1]perlecan[/E1], weak binding by [E2]decorin[/E2] and biglycan, two dermatan sulfate proteoglycans, and lack of binding by versican/PG-M, a large chondroitin sulfate proteoglycan", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "perlecan", "entity_1_idx": [[85, 93]], "entity_1_idx_in_text_with_entity_marker": [89, 97], "entity_1_type": "pm0116983", "entity_1_type_id": 114, "entity_2": "decorin", "entity_2_idx": [[111, 118]], "entity_2_idx_in_text_with_entity_marker": [124, 131], "entity_2_type": "pm0108608", "entity_2_type_id": 116}], "directed": false, "reverse": false}
{"id": "HPRD50.d36.s0_HPRD50.d36.s0.p0", "text": "CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation", "text_with_entity_marker": "[E1]CD22[/E1] associates with [E2]protein tyrosine phosphatase 1C[/E2], Syk, and phospholipase C-gamma(1) upon B cell activation", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CD22", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "pm0119833", "entity_1_type_id": 135, "entity_2": "protein tyrosine phosphatase 1C", "entity_2_idx": [[21, 52]], "entity_2_idx_in_text_with_entity_marker": [34, 65], "entity_2_type": "pm0105676", "entity_2_type_id": 136}], "directed": false, "reverse": false}
{"id": "HPRD50.d36.s2_HPRD50.d36.s2.p1", "text": "The association of PTP-1C with CD22 was mediated by the NH2-terminal Src homology 2 (SH2) domain of PTP-1C", "text_with_entity_marker": "The association of [E1]PTP-1C[/E1] with CD22 was mediated by the NH2-terminal Src homology 2 (SH2) domain of [E2]PTP-1C[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PTP-1C", "entity_1_idx": [[19, 25]], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_type": "pm0105676", "entity_1_type_id": 136, "entity_2": "PTP-1C", "entity_2_idx": [[100, 106]], "entity_2_idx_in_text_with_entity_marker": [113, 119], "entity_2_type": "pm0105676", "entity_2_type_id": 136}], "directed": false, "reverse": false}
{"id": "HPRD50.d36.s4_HPRD50.d36.s4.p1", "text": "Transient expression of CD22 and a null mutant of PTP-1C (PTP-1CM) in COS cells resulted in an increase in tyrosyl phosphorylation of CD22 and its interaction with PTP-1CM", "text_with_entity_marker": "Transient expression of [E1]CD22[/E1] and a null mutant of PTP-1C (PTP-1CM) in COS cells resulted in an increase in tyrosyl phosphorylation of [E2]CD22[/E2] and its interaction with PTP-1CM", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD22", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "pm0119833", "entity_1_type_id": 135, "entity_2": "CD22", "entity_2_idx": [[134, 138]], "entity_2_idx_in_text_with_entity_marker": [147, 151], "entity_2_type": "pm0119833", "entity_2_type_id": 135}], "directed": false, "reverse": false}
{"id": "HPRD50.d37.s0_HPRD50.d37.s0.p2", "text": "TFIID dimers formed through self-association of the TATA-binding polypeptide (TBP) subunit and could be immunoprecipitated with antibodies to TAF(II)250, the core subunit of TFIID", "text_with_entity_marker": "[E1]TFIID[/E1] dimers formed through self-association of the TATA-binding polypeptide (TBP) subunit and could be immunoprecipitated with antibodies to TAF(II)250, the core subunit of [E2]TFIID[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "pm0109127", "entity_1_type_id": 137, "entity_2": "TFIID", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "pm0109127", "entity_2_type_id": 137}], "directed": false, "reverse": false}
{"id": "HPRD50.d37.s0_HPRD50.d37.s0.p4", "text": "TFIID dimers formed through self-association of the TATA-binding polypeptide (TBP) subunit and could be immunoprecipitated with antibodies to TAF(II)250, the core subunit of TFIID", "text_with_entity_marker": "TFIID dimers formed through self-association of the TATA-binding polypeptide ([E1]TBP[/E1]) subunit and could be immunoprecipitated with antibodies to TAF(II)250, the core subunit of [E2]TFIID[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[78, 81]], "entity_1_idx_in_text_with_entity_marker": [82, 85], "entity_1_type": "pm0109127", "entity_1_type_id": 137, "entity_2": "TFIID", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "pm0109127", "entity_2_type_id": 137}], "directed": false, "reverse": false}
{"id": "HPRD50.d38.s0_HPRD50.d38.s0.p9", "text": "Subsequent amino acid sequencing revealed many peptides involving involucrin cross-linked either to itself or to a variety of other known CE protein components, including cystatin alpha, desmoplakin, elafin, keratins, members of the small proline-rich superfamily, loricrin, and unknown proteins related to the desmoplakin family", "text_with_entity_marker": "Subsequent amino acid sequencing revealed many peptides involving involucrin cross-linked either to itself or to a variety of other known CE protein components, including cystatin alpha, [E1]desmoplakin[/E1], [E2]elafin[/E2], keratins, members of the small proline-rich superfamily, loricrin, and unknown proteins related to the desmoplakin family", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmoplakin", "entity_1_idx": [[187, 198]], "entity_1_idx_in_text_with_entity_marker": [191, 202], "entity_1_type": "pm0110549", "entity_1_type_id": 141, "entity_2": "elafin", "entity_2_idx": [[200, 206]], "entity_2_idx_in_text_with_entity_marker": [213, 219], "entity_2_type": "pm0114270", "entity_2_type_id": 142}], "directed": false, "reverse": false}
{"id": "HPRD50.d42.s2_HPRD50.d42.s2.p1", "text": "Bcl3 specifically interacted with the general transcription factors TFIIB, TBP, and TFIIA but not with TFIIEalpha in the GST pull-down assays", "text_with_entity_marker": "[E1]Bcl3[/E1] specifically interacted with the general transcription factors TFIIB, TBP, and [E2]TFIIA[/E2] but not with TFIIEalpha in the GST pull-down assays", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Bcl3", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "pm0126712", "entity_1_type_id": 151, "entity_2": "TFIIA", "entity_2_idx": [[84, 89]], "entity_2_idx_in_text_with_entity_marker": [97, 102], "entity_2_type": "pm0112153||pm0118250", "entity_2_type_id": 154}], "directed": false, "reverse": false}
{"id": "HPRD50.d42.s2_HPRD50.d42.s2.p4", "text": "Bcl3 specifically interacted with the general transcription factors TFIIB, TBP, and TFIIA but not with TFIIEalpha in the GST pull-down assays", "text_with_entity_marker": "Bcl3 specifically interacted with the general transcription factors [E1]TFIIB[/E1], TBP, and TFIIA but not with TFIIEalpha in the [E2]GST[/E2] pull-down assays", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIIB", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "pm0112772", "entity_1_type_id": 153, "entity_2": "GST", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "pm0116848", "entity_2_type_id": 31}], "directed": false, "reverse": false}
